Compass Therapeutics, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
CMPX on Nasdaq
Location
80 Guest Street, Boston, MA

There are no Buy or Sell transactions made by insiders since 12/22/2023

Compass Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Orbimed Advisors Llc Director, 10%+ Owner $29.4M Nov 8, 2022
Thomas J. Schuetz PRESIDENT, Director $9.53M Feb 8, 2024
Vered Bisker-Leib CHIEF EXECUTIVE OFFICER, Director $4.53M Feb 8, 2024
Barry Shin Cfo $660K Dec 9, 2024
Neil Lerner VP Finance $435K Dec 9, 2024
Jonathan Anderman Sr VP, Gen Counsel & Corp Sec $1.45K Aug 13, 2024
Richard S. Lindahl Director Feb 9, 2024
Susan Kalled Chief Scientific Officer Feb 18, 2022
Brett Kaplan Director Feb 18, 2022
Philip Ferneau Director Feb 9, 2024
David M. Wurzer Director Feb 8, 2023
Stephen P. Squinto Director Feb 18, 2022
Miranda Jayne Toledano Director Jun 25, 2021
Carl L. Gordon Director, 10%+ Owner Feb 9, 2024
Ellen Chiniara Director Feb 9, 2024
James P. Boylan Director Mar 8, 2024
Mary Ann Gray Director Feb 9, 2024

Recent Insider Transactions by Companies or Individuals for Compass Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.